Data / Form D filings / NEUROONE MEDICAL TECHNOLOGIES Corp
NEUROONE MEDICAL TECHNOLOGIES Corp: Form D filings
NEUROONE MEDICAL TECHNOLOGIES Corp, a biotechnology company in Eden Prairie, MN, filed 15 Form D notices with the SEC between 2017 and 2024. The latest, on August 16, 2024, reports $276,043 sold of a $276,043 offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7599 ANAGRAM DR, Eden Prairie, MN, 55344
- Phone
- (952) 426-1383
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1500198
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | New notice | $276,043 | $276,043 | 20 | Aug 2, 2024 | sec.gov | |
| Jan 27, 2021 | New notice | $12,500,000 | $12,500,000 | 36 | Jan 14, 2021 | sec.gov | |
| Aug 10, 2020 | New notice | $135,000 | $135,000 | 1 | Jul 28, 2020 | sec.gov | |
| May 14, 2020 | New notice | $6,000,000 | $2,469,800 | $3,530,200 | 33 | Apr 30, 2020 | sec.gov |
| Nov 7, 2019 | New notice | $3,000,000 | $1,253,000 | $1,747,000 | 16 | Nov 1, 2019 | sec.gov |
| Nov 7, 2019 | New notice | $1,000,000 | $255,000 | $745,000 | 3 | Oct 23, 2019 | sec.gov |
| Feb 27, 2019 | Amendment | $10,000,000 | $1,538,000 | $8,462,000 | 21 | Jul 9, 2018 | sec.gov |
| Feb 27, 2019 | Amendment | $10,000,000 | $992,500 | $9,007,500 | 17 | Dec 28, 2018 | sec.gov |
| Jan 4, 2019 | New notice | $10,000,000 | $400,000 | $9,600,000 | 3 | Dec 28, 2018 | sec.gov |
| Jul 24, 2018 | New notice | $10,000,000 | $538,000 | $9,462,000 | 4 | Jul 9, 2018 | sec.gov |
| May 23, 2018 | Amendment | $2,000,000 | $1,490,000 | $510,000 | 20 | Oct 4, 2017 | sec.gov |
| Dec 21, 2017 | Amendment | $1,500,000 | $665,000 | $835,000 | 12 | Oct 4, 2017 | sec.gov |
| Oct 18, 2017 | New notice | $1,000,000 | $150,000 | $850,000 | 3 | Oct 4, 2017 | sec.gov |
| Aug 29, 2017 | New notice | $300,000 | $253,000 | $47,000 | 2 | Aug 18, 2017 | sec.gov |
| Aug 2, 2017 | New notice | Indefinite | $0 | 19 | Jul 20, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey S. Mathiesen | Director | |
| Ronald A. McClurg | Executive Officer | |
| Paul A. Buckman | Director | |
| David A. Rosa | Executive Officer, Director | |
| Edward A. Andrle | Director | |
| Mark A. Christianson | Executive Officer | |
| Steve A. Mertens | Executive Officer | |
| Christopher A. Volker | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Aug 12, 2024 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEUROONE MEDICAL TECHNOLOGIES Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.